Table 2.
EC transporters and their functions.
| Component | Function | Diseased condition | Expression | Reference | |
|---|---|---|---|---|---|
| Nutrient transporters | Glucose transporter 1 (GLUT1) protein | Regulates glucose level in brain | Hypoxia-ischemia elevates GLUT1 expression, which serves a neuroprotective role by reducing focal ischemia | Disperse | Shi et al., 1997; Vemula et al., 2009; Li et al., 2013 |
| Sodium-glucose transporter (SGLT) protein | Materials transport; cell depolarization; glucose level maintenance | Increases edema formation and exacerbates cerebral ischemic neuronal injury; inhibition of SGLT during stroke improves outcome | Vemula et al., 2009; Yamazaki et al., 2015; Yamazaki et al., 2016; Sifat et al., 2017 | ||
| Ion transporters | Na+-K+-Cl− co-transporter | Maintain CNS ion content | Hypoxia stimulates Na+-K+-Cl− cotransporter expression leading to brain edema formation | Luminal | Foroutan et al., 2005; Jayakumar and Norenberg, 2010 |
| Na+/K+-ATPase | Decreased Na+/K+-ATPase expression causes the accumulation of Na+ leading to endothelial swelling and cytotoxic edema | Abluminal | Babsky et al., 2008; Hladky and Barrand, 2016; Jiang et al., 2018 | ||
| Ca2+-ATPase | Ca2+-ATPase fails to maintain ion homeostasis in the setting of stroke due to ATP loss | Luminal | Jiang et al., 2018 | ||
| ATP-binding cassette (ABC) transporters | P-glycoprotein (P-gp) | Efflux pumps most notably regulating drug transport | Differentially expressed in neurological disorders | Luminal | Abbott et al., 2010; Qosa et al., 2015; Jiang et al., 2018 |
| Breast cancer resistance protein (Bcrp) | |||||
| Multidrug resistance-associated proteins (Mrps) | |||||